StarlinePS Enterprises Limited has made a regulatory disclosure to BSE Limited regarding a significant investment decision approved by its Board of Directors.
The Board has approved an investment of ₹160 Crore (Rupees One Hundred Sixty Crore) to acquire 50% of the aggregate post-money paid-up equity share capital of Celloraa Energy Private Limited ("Target Entity"). This investment will be made by subscribing to new equity shares of the Target Entity through cash consideration.
The acquisition will be executed in one or more tranches and is subject to:
- Completion of customary conditions precedent
- Relevant regulatory approvals as required under applicable laws
- Approval from the shareholders of StarlinePS Enterprises Limited
The expected timeline for completion is within the next 12 months, contingent upon fulfilling all conditions and obtaining necessary approvals.
Target Entity Details
Name: Celloraa Energy Private Limited
Industry: Manufacturing of Solar Cell
Date of Incorporation: 6th February, 2026
Capital Structure:
- Authorized Share Capital: ₹1,00,00,000 (One Crore) divided into 10,00,000 equity shares of ₹10 each
- Paid-up Share Capital: ₹2,50,000 (Two Lakhs Fifty Thousand) divided into 25,000 equity shares of ₹10 each
Financial Performance:
- Turnover for 2025-26: NIL
- Turnover for 2024-25: NA
- Turnover for 2023-24: NA
Transaction Specifics
Investment Structure: Cash consideration for subscription of new equity shares
Cost per Share: ₹64,000 per share
Total Investment Value: ₹160 Crore
Resulting Shareholding: 50% of post-money paid-up equity share capital
Regulatory Compliance: The disclosure is made pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Related Party Status: The proposed acquisition does not qualify as a related party transaction. No promoters/promoter group/group companies have any interest in the target entity.
Objects and Impact: Not specified in the disclosure.
Governmental/Regulatory Approvals: Not specified in the disclosure.